Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Net Cash Flow (2020 - 2025)

Bio Essence (BIOE) has 6 years of Net Cash Flow data on record, last reported at $28741.0 in Q3 2025.

  • For Q3 2025, Net Cash Flow fell 82.73% year-over-year to $28741.0; the TTM value through Sep 2025 reached -$147177.0, down 166.85%, while the annual FY2024 figure was $1257.0, 96.7% down from the prior year.
  • Net Cash Flow reached $28741.0 in Q3 2025 per BIOE's latest filing, up from -$1371.0 in the prior quarter.
  • Across five years, Net Cash Flow topped out at $422431.0 in Q2 2023 and bottomed at -$409350.0 in Q3 2023.
  • Average Net Cash Flow over 5 years is $22333.8, with a median of $943.5 recorded in 2022.
  • The widest YoY moves for Net Cash Flow: up 29317.2% in 2023, down 90864.97% in 2023.
  • A 5-year view of Net Cash Flow shows it stood at -$26410.0 in 2021, then surged by 1367.7% to $334800.0 in 2022, then plummeted by 86.79% to $44239.0 in 2023, then crashed by 494.55% to -$174547.0 in 2024, then skyrocketed by 116.47% to $28741.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were $28741.0 in Q3 2025, -$1371.0 in Q1 2025, and -$174547.0 in Q4 2024.